Concepedia

Sylvia Ma

SM

Statistics

Publications

16

Citations

833

H-Index

15

Active since

1978

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Novartis (China)

King's College London

Sylvia Ma is an author at Novartis (United States) specializing in drug discovery, medicinal chemistry, and drug design.

Publications per year

1978–2021

16

Publications

16

CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons <i>In vitro</i> and <i>In vivo</i>

Archie Tse, Katherine G. Rendahl, Tahir Sheikh et al. · Clinical Cancer Research · 2007 · 150 citations

, , +17

Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor

Alexei S. Karpov, Payman Amiri, Cornelia Bellamacina et al. · ACS Medicinal Chemistry Letters · 2015 · 109 citations · Full text

, , +16

Design and Synthesis of Orally Bioavailable Benzimidazoles as Raf Kinase Inhibitors

Savithri Ramurthy, Sharadha Subramanian, Mina Aikawa et al. · Journal of Medicinal Chemistry · 2008 · 76 citations · Full text

, , +13

4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors

Zhi‐Jie Ni, Paul A. Barsanti, Nathan Brammeier et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 71 citations · Full text

, , +7

A Comparative Analysis of Determinant Attributes in Retail Store Selection

S. Arnold, Sylvia Ma, Douglas J. Tigert · ACR North American Advances · 1978 · 68 citations

, , +15

1–5 of 16